Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115197220B details a metal-free organocatalytic route for high-purity delta-lactam spiro indoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN107235952A details efficient Fuanmycin skeleton synthesis offering supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel cyclization method reduces costs and improves yield for thiamphenicol manufacturing. Enhances supply chain reliability for global pharmaceutical buyers.
Patent CN104262249A reveals solvent-free hydroamination for quinolones. Reduces waste and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN115197199A details a high-yield palladium-catalyzed method for chiral indolinone arylamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Lewis acid catalyzed cyclization route for azepino[4,5-b]indole intermediates. Offers mild conditions and high scalability for API manufacturing.
Patent CN112174837B reveals a novel Boc-protected aziridine route for high-purity chiral amine intermediates, offering significant cost reduction and supply chain reliability for asthma drug manufacturing.
Patent CN1115755A details an eco-friendly electrochemical route for 3-aminopyridines, offering significant cost reduction in API manufacturing and eliminating heavy metal waste.
Novel glycine-based route for PHA739358 reduces steps and cost while ensuring 99% purity for reliable pharmaceutical intermediate supply chains.
Patent CN107955029A details a high-yield Lesinurad synthesis. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN104230924B enables low-temperature synthesis reducing impurities. Reliable supply chain for high-purity API intermediates ensures cost reduction and continuity.
Patent CN118996448A reveals electrochemical alkyne reduction for deuterated olefins. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced patent CN115160202B enables high-yield Carboprost Tromethamine production. Optimized for cost reduction and supply chain reliability in pharmaceutical intermediates.
Patent CN103467276B offers a safer route for Montelukast intermediates ensuring supply chain reliability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN108546266B details a safe, scalable route for 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylic acid, offering significant cost reduction in API manufacturing.
Novel synthesis of Relugolix intermediate impurity Formula VI via hydrolysis and cyclization. Enhances QC capabilities for API manufacturing.
Novel catalytic hydrogenation process ensures high purity and yield for 1-amino-1-deoxy-D-glucitol manufacturing with significant supply chain cost advantages.
Patent CN104072477B details a high-purity imatinib refining method controlling genotoxic impurities. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel synthesis for α-deuterated methyl aryl propionic acids. Enhances metabolic stability. Reliable supplier for pharma intermediates.